Sight Sciences, Inc.(SGHT)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Sight Sciences, Inc. (SGHT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SGHT at 18.9/100 on a 32-signal composite quality model, placing it at rank #2,800 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (8.8) and free cash flow (11.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 10.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Sight Sciences, Inc. reports quarterly revenue of $23.4M, net income of $-4.4M, free cash flow of $-5.7M. Top institutional holders of SGHT by reported 13-F value include Long Focus Capital Management, BlackRock, Americana Partners, based on the most recent SEC filings. SGHT trades on the Nasdaq exchange and files with the SEC under CIK 1531177. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SGHT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sight Sciences, Inc. directly from SEC EDGAR.

AI Quality Score

18.9/100

AI Rank

#2,800

Revenue

$23.4M

Net Income

$-4.4M

Free Cash Flow

$-5.7M

SGHT key financials by period

Sight Sciences, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$77.4M$-38.4M-47.9%
FY 202410-K$79.9M$-51.5M-63.3%
FY 202310-K$81.1M$-55.5M-70.7%
FY 202210-K$71.3M$-86.2M-117.7%
FY 202110-K$49.0M$-63.0M-105.2%
FY 202010-K$27.6M$-34.7M-116.5%

Institutions holding SGHT

Institutional investors reporting a position in Sight Sciences, Inc. on SEC Form 13F.
InstitutionSharesValueReported
Long Focus Capital Management3,844,100$20.8M2026-06-30
BlackRock3,083,108$16.7M2026-06-30
Americana Partners1,679,069$9.1M2026-06-30
Pathstone1,678,980$9.1M2026-06-30
VANGUARD CAPITAL MANAGEMENT1,573,815$8.5M2026-06-30
GEODE CAPITAL MANAGEMENT958,565$5.2M2026-06-30
STATE STREET835,452$4.5M2026-06-30
ACADIAN ASSET MANAGEMENT806,576$4.4M2026-06-30
B Group970,000$3.7M2026-06-30
AQR CAPITAL MANAGEMENT397,558$2.2M2026-06-30
SGHT

Sight Sciences, Inc.

SGHT
NasdaqSmall CapHealthcare

13F Pro Quality Score

18.9/100

Rank #2,800 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

23.1/100

Profitability

13.4/100

Balance Sheet

8.8/100

Earnings Quality

24.4/100

Free Cash Flow

11.7/100

Institutional Flow

17.3/100

Revenue Scale

13.3/100

Dilution Risk

10.7/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$23.39M

Net Income

Q2 2026
EDGAR

$-4.45M

EPS (Diluted)

Q2 2026
EDGAR

$-0.08

ROIC

Q2 2026
EDGAR

-16.6%

Free Cash Flow

Q2 2026
EDGAR

$-5.68M

Debt/Equity

Q2 2026
EDGAR

0.77

Top Institutional Holders

as of Q2 2026
$118.47M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…